.avif)
Accuray Email Format
Medical Equipment Manufacturing
・
501-1,000 employees
・
Madison, WI, USA
Accuray is a medical equipment manufacturing company that develops advanced radiation therapy systems including CyberKnife and TomoTherapy to expand cancer treatment options worldwide.
Search our verified sources for decision-makers, emails, and titles.
Start searching
VERIFIED BY CLAY
firstinitiallast@accuray.com
Company Overview
Industry
Medical Equipment Manufacturing
Founded
1990
Headquarters
Madison, WI, USA
Revenue
$250M-$500M
FUNDING Stage
Public
Website
Key Executives
Steve La Neve (President and Chief Executive Officer), Ali Pervaiz (Senior Vice President, Chief Financial Officer), Mu Young Lee (Senior Vice President, Research & Product Development)
Tech Stack
Key Executives
4.9/5 on G2
40K+ GTM professionals
SOC 2 Type II certified
Frequently Asked Questions
What is the email format of Accuray?
Accuray uses the firstinitiallast format, so Jane Smith would be jsmith@accuray.com.
What radiation therapy systems does Accuray sell?
Accuray sells the CyberKnife System for robotic radiosurgery and the Radixact Treatment Delivery System, which includes the Stellar adaptive radiotherapy solution. These platforms treat cancerous and benign tumors across a broad range of oncology and neuro-radiosurgery indications.
How can I find and verify the right Accuray contact for my outreach?
Because Accuray uses the firstinitiallast format at accuray.com, you can build likely addresses from any employee's name. Tools like Clay can confirm whether a specific Accuray address is valid and deliverable before you send outreach to a clinician, regional sales lead, or executive.
Who leads Accuray's research and product development in 2026?
Mu Young Lee serves as Senior Vice President of Research and Product Development at Accuray, overseeing the engineering and innovation roadmap that includes platforms like the Stellar adaptive radiotherapy solution and the CyberKnife S7 System.
What is Accuray's 10-year research agreement with the University of Wisconsin-Madison focused on in 2026?
Announced in May 2026, the Master Research Agreement between Accuray and the University of Wisconsin-Madison centers on advancing personalized cancer care using Accuray's Stellar adaptive radiation therapy platform, supporting clinical research, education, training, and next-generation adaptive therapy development.
Get access to more people and company data using Clay
Leverage the power of 100+ data providers for industry-leading data coverage & quality.
4.9 rating